EUCTR2006-006231-49-DE进行中（未招募）1 期
Ranibizumab in choroidal neovascularization (CNV) due to Pseudoxanthoma elasticum (PXE, Groenblad-Strandberg Syndrome) - PXE-CNV 06
Department of Ophthalmology, Bonn University0 个研究点目标入组 10 人开始时间: 2007年3月6日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •18 – 65 yrs. of age.
- •PXE-diagnosis ascertained by genetic analysis.
- •Angiographically diagnosed CNV in the study eye.
- •Written informed consent.
- •Best corrected visual acuity: 20/200 – 20/32 in the study eye.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patients with other retinal diseases including diseases of the retinal vessels or diabetic retinopathy.
- •Ocular surgery mess than three months prior to the commencment of the trial.
- •History of a not well meneged glaucoma.
- •Active intraocular inflammation or inflammation of the ocular adnexa.
- •Subfoveal fibrosis in the study eye.
- •Inability, to comply with the study protocol.
- •Major surgical interventions less than 1 month prior to the commencment of the trial.
- •Known allergy to humanized antibodies.
- •History of clinically significant cardiovascular or cerebrovascular disease less than 6 months before commencment of the trial
研究者
相似试验
已完成
2 期
Ranibizumab to Treat Choroidal Neovascularization (CNV) in Patients With Pseudoxanthoma Elasticum (PXE)Choroidal NeovascularizationNCT00510965University Hospital, Bonn10
撤回
1 期
Ranibizumab Therapy for Choroidal Neovascularization (CNV) Asociated With Angioid StreaksAngioid StreaksNCT01015495University of Illinois at Chicago
已完成
1 期
Ranibizumab in Hemorrhagic Choroidal Neovascularization TrialChoroidal NeovascularizationNCT00363168Johns Hopkins University7
已完成
不适用
Intravitreal ranibizumab for patients with neovascular age-related macular degeneration with good baseline visual acuityneovascular age-related macular degenerationJPRN-UMIN000015073Department of Ophthalmology and Visual Science, Nagoya City University Graduate School of Medical Sciences40
已完成
4 期
Pilot Study of Ranibizumab With and Without Ketorolac Eyedrops for Exudative Age-related Macular DegenerationWet Macular DegenerationNCT02060604Università degli Studi di Brescia60